by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersWizcure Pharmaa Private Limited

All Warning Letters

Wizcure Pharmaa Private Limited

Warning LetterOpen

PGN 02-1403, Emaar Palm Gardens Sector 83 Gurgaon 122004 Haryana IndiaFEI 3030304532Issued Jun 24, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3030304532.

Violations5

Issue DateJun 24, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Wizcure Pharmaa Private Limited
Location: PGN 02-1403, Emaar Palm Gardens Sector 83 Gurgaon 122004 Haryana India
FEI Number: 3030304532
Country: India
Issue Date: June 24, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Wizcure Pharmaa Private Limited FDA Warning Letter, June 24, 2026